YNIOS Pharma
ActiveSummary
The computed 12-month bankruptcy probability of YNIOS Pharma is 3.1% (moderate). The 2025 annual accounts show equity of €473,563 and a net result of -€228,903. Equity is growing by about 61% per year across the filed financial years. Its solvency ranks better than 72% of 146 sector peers (NACE 20, financial year 2025). The company has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals.
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
08-07
Gazette deed
Permanent representative: Philippe VAN WESEPOELRegistered-office move5 facts ▸
Gazette deed
Permanent representative: Philippe VAN WESEPOEL
Registered-office move5 facts ▸
- Board meeting, 21-05-2026
- Director in office, PLUCKER Jean François (administrateur/directeur associé)
- Director in office, WESCONS Srl (administrateur/directeur associé)
- Permanent representative, Philippe VAN WESEPOEL
- Registered-office move, 32 Avenue Wolfers,1310 La Hulpe,Belgique
12-06
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
31-12
Financial
Weakest financial yearnet -€228,903
Net result drops to -€228,903, the lowest in the series.
01-08
NBB filing
Annual accounts filed
financial year 2024 · micro format · 1 day late
2024
31-12
Financial
Back to profitnet €342,124
Net result €342,124 after 2 loss-making years.
31-12
Financial
Equity above €500,000equity €702,466 ▲830%
Equity rises from €75,542 to €702,466.
06-12
Gazette deed
Capital & shares · Amendment of the articles · MiscellaneousShare issue · Bank account · Declaration7 facts ▸
Gazette deed
Capital & shares · Amendment of the articles · Miscellaneous
Share issue · Bank account · Declaration7 facts ▸
- General meeting, 08-08-2024
- Share issue, “CBC Banque, B1” (deed in French)
- Other provision, “au profit du souscripteur désigné, renonciation au droit de souscription préférentiel article 7” (deed in French)
- Bank account, “CBC Banque, BE71 7320 6592 3069” (deed in French)
- Declaration, “B2”, 87400 (deed in French)
- Kind of shares, “B4 (PRIVES Normal)” (deed in French)
- Amendment of the articles, 5
02-07
NBB filing
Annual accounts filed
financial year 2023 · micro format
10-06
Gazette deed
Capital & shares · Amendment of the articles · MiscellaneousKind of shares · Share issue · Bank account16 facts ▸
Gazette deed
Capital & shares · Amendment of the articles · Miscellaneous
Kind of shares · Share issue · Bank account16 facts ▸
- General meeting, 19-03-2024
- Other provision, “remplacement des actions existantes”, 5370000 (deed in French)
- Kind of shares, 7600, 87400
- Share issue, 7600, 7600
- Other provision, “souscriptions B1 et B2, renonciation au droit de souscription préférentiel” (deed in French)
- Share issue, “B1”, 7600 (deed in French)
- Share issue, “B2”, 87400 (deed in French)
- Bank account, “BE71 7320 6592 3069, libération souscriptions B1 et B2” (deed in French)
- Other provision, “précisions souscriptions B1 et B2”, 87400 (deed in French)
- Share issue, 2700, “SPREDS FINANCE Normal” (deed in French)
- Other provision, “souscriptions B3 et B4, renonciation au droit de souscription préférentiel” (deed in French)
- Share issue, “B3”, 2700 (deed in French)
- +4 further facts in this act
2023
31-12
Financial
Liquidity more than doubledcurrent ratio 1.18
Current ratio from 0.43 to 1.18; short-term debt falls from €55,095 to €43,115.
13-07
NBB filing
Annual accounts filed
financial year 2022 · micro format
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
3 of 6 deeds read
About the unread acts
Of the 6 Belgian Official Gazette deeds we know for this company, 3 have been read. The other 3 have not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.